Evolution of the Average Target: Johnson & Johnson

Evolution of the Target Price: Johnson & Johnson

Changes in Analyst Recommendations: Johnson & Johnson

91f9097d.hx5y6dc2mq1-wVm6JxvUhHn7uFzNpp16_oXbtF0733w.9lgVkJpX2ekEthLjXUSN6g2v_zH_0OQwrtGY_zVflTm_bQCg71rZ2TegKg~090a4526f70aa8871af053e056833d4a
05-13 Leerink Partners Upgrades Johnson & Johnson to Outperform From Market Perform, Adjusts PT to $265 From $252 MT
04-30 AbbVie Expected to Post Durable Growth Into Mid-2030s, BofA Securities Says MT
04-20 Guggenheim Adjusts Price Target on Johnson & Johnson to $266 From $244, Maintains Buy Rating MT
04-16 Daiwa Securities Adjusts PT on Johnson & Johnson to $246 From $237, Maintains Outperform Rating MT
04-16 Argus Research Adjusts PT on Johnson & Johnson to $275 From $240, Maintains Buy Rating MT
04-15 Argus Raises Price Target on Johnson & Johnson to $275 From $240 MT
04-15 BofA Securities Raises Price Target on Johnson & Johnson to $254 From $253, Maintains Neutral Rating MT
04-15 Johnson & Johnson Reported Above-Peer Topline Growth in Q1, BofA Says MT
04-15 BofA Securities Raises Price Target on Johnson & Johnson to $254 From $253, Maintains Neutral Rating MT
04-15 Johnson & Johnson Q1 Reinforces Growth Outlook on New Product Cycle, Morgan Stanley Says MT
04-15 Johnson & Johnson Highlights Pipeline Catalysts, Reaffirms Growth Outlook After Q1 Beat, RBC Says MT
04-15 RBC Raises Price Target on Johnson & Johnson to $265 From $255, Keeps Outperform Rating MT
04-15 Morgan Stanley Lifts Price Target on Johnson & Johnson to $283 From $267, Maintains Overweight Rating MT
04-15 Stifel Adjusts Price Target on Johnson & Johnson to $250 From $220, Maintains Hold Rating MT
04-15 Barclays Adjusts Price Target on Johnson & Johnson to $255 From $234, Maintains Equalweight Rating MT
04-15 Goldman Sachs Adjusts Price Target on Johnson & Johnson to $275 From $265, Maintains Buy Rating MT
04-15 Wells Fargo Adjusts Price Target on Johnson & Johnson to $263 From $240, Maintains Overweight Rating MT
04-15 Bernstein Adjusts Price Target on Johnson & Johnson to $251 From $225, Maintains Market Perform Rating MT
04-15 JPMorgan Adjusts Price Target on Johnson & Johnson to $260 From $250, Maintains Neutral Rating MT
04-15 Leerink Partners Adjusts PT on Johnson & Johnson to $252 From $232, Maintains Market Perform Rating MT
04-15 Raymond James Adjusts PT on Johnson & Johnson to $258 From $237, Maintains Outperform Rating MT
04-09 Biopharma Stocks Largely Exempt From Pharma Tariffs, BofA Says MT
04-07 Citigroup Adjusts Price Target on Johnson & Johnson to $285 From $274, Maintains Buy Rating MT
04-07 Guggenheim Adjusts Price Target on Johnson & Johnson to $244 From $240, Maintains Buy Rating MT
03-30 Johnson & Johnson's Vision Segment Targets Up to High-Single Digit Long-Term Growth, RBC Says MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+9.78%
+19.12%
+21.31%
+12.74%
+19.29%
+4.09%
+14.36%
+2.94%
+4.69%
+18.73%
Average +12.71%
Weighted average by Cap. +14.05%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
230.42USD
Average target price
252.96USD
Spread / Average Target
+9.78%
High Price Target
285.00USD
Spread / Highest target
+23.69%
Low Price Target
155.00USD
Spread / Lowest Target
-32.73%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Leerink Partners
Guggenheim
Daiwa Securities
Argus
BofA Securities
RBC Capital Markets
Morgan Stanley
Barclays
Raymond James
JPMorgan Chase
Bernstein
Wells Fargo Securities
Goldman Sachs
Stifel Nicolaus
Citigroup
HSBC
Rothschild & Co Redburn
Wolfe Research
Scotiabank
TD Cowen
UBS
DBS Bank
Redburn Atlantic
DZ Bank
Atlantic Equities
Credit Suisse
SVB Securities LLC
DA Davidson
SVB Financial
Sanford Bernstein
Cantor Fitzgerald
J.P. Morgan Chase
Cowen
SVB Leerink
RBC Brandon Henry
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
230.42USD
Average target price
252.96USD
Spread / Average Target
+9.78%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. JNJ Stock
  4. Consensus Johnson & Johnson